Full Text Journal Articles by
Author Norman L Foster

Advertisement

Find full text journal articles






Changes in the Auditory Association Cortex in Dementing Illnesses.

Alana Aylward, Priscilla Auduong, Jeffrey S Anderson, Brandon A Zielinski, Angela Y Wang, Cindy Weng, Norman L Foster, Richard K Gurgel,

OBJECTIVE:To evaluate the relationship between degree of cognitive impairment and gray-matter density changes in the auditory cortex. STUDY DESIGN:Retrospective case-control. PATIENTS:Six hundred sixty-three patients of a tertiary referral center cognitive disorders clinic. INTERVENTION:Magnetic resonance imaging. MAIN OUTCOME MEASURES:Ratios of gray matter density of the primary auditory cortex (A1) to whole ... Read more >>

Otol Neurotol (Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology)
[2020, 41(10):1327-1333]

Cited: 0 times

View full text PDF listing >>



Left Ear Hearing Predicts Functional Activity in the Brains of Patients with Alzheimer's Disease Dementia.

Alana Aylward, Susan R Naidu, Catherine Mellum, Jace B King, Keith G Jones, Jeffrey S Anderson, Norman L Foster, Richard K Gurgel,

OBJECTIVES:To determine whether central speech processing ability, as measured by hearing in noise, differs between right and left ears in adults with Alzheimer's disease related dementia (AD) as well as whether differences in central speech processing ability correlate with an fMRI-based measurement of global functional brain connectivity. METHODS:This prospective study ... Read more >>

Ann Otol Rhinol Laryngol (The Annals of otology, rhinology, and laryngology)
[2020, :3489420952467]

Cited: 0 times

View full text PDF listing >>



Advertisement

Quality improvement in neurology: Mild cognitive impairment quality measurement set.

Norman L Foster, Mark W Bondi, Rohit Das, Mary Foss, Linda A Hershey, Steve Koh, Rebecca Logan, Carol Poole, Joseph W Shega, Ajay Sood, Niranjan Thothala, Meredith Wicklund, Melissa Yu, Amy Bennett, David Wang,

Neurology (Neurology)
[2019, 93(16):705-713]

Cited: 0 times

View full text PDF listing >>



Relative risk for Alzheimer disease based on complete family history.

Lisa A Cannon-Albright, Norman L Foster, Karen Schliep, James M Farnham, Craig C Teerlink, Heydon Kaddas, Joann Tschanz, Chris Corcoran, John S K Kauwe,

OBJECTIVE:The inherited component for Alzheimer disease (AD) risk has focused on close relatives; consideration of the full family history may improve accuracy and utility of risk estimates. METHODS:A population resource including a genealogy of Utah pioneers from the 1800s linked to Utah death certificates was used to estimate relative risk ... Read more >>

Neurology (Neurology)
[2019, 92(15):e1745-e1753]

Cited: 2 times

View full text PDF listing >>



Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients.

William Perry, Laura Lacritz, Tresa Roebuck-Spencer, Cheryl Silver, Robert L Denney, John Meyers, Charles E McConnel, Neil Pliskin, Deb Adler, Christopher Alban, Mark Bondi, Michelle Braun, Xavier Cagigas, Morgan Daven, Lisa Drozdick, Norman L Foster, Ula Hwang, Laurie Ivey, Grant Iverson, Joel Kramer, Melinda Lantz, Lisa Latts, Shari M Ling, Ana Maria Lopez, Michael Malone, Lori Martin-Plank, Katie Maslow, Don Melady, Melissa Messer, Randi Most, Margaret P Norris, David Shafer, Nina Silverberg, Colin M Thomas, Laura Thornhill, Jean Tsai, Nirav Vakharia, Martin Waters, Tamara Golden,

Summit Participants: Organizations Represented: ... Read more >>

Arch Clin Neuropsychol (Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists)
[2018, 33(6):655-675]

Cited: 1 time

View full text PDF listing >>



Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients.

William Perry, Laura Lacritz, Tresa Roebuck-Spencer, Cheryl Silver, Robert L Denney, John Meyers, Charles E McConnel, Neil Pliskin, Deb Adler, Christopher Alban, Mark Bondi, Michelle Braun, Xavier Cagigas, Morgan Daven, Lisa Drozdick, Norman L Foster, Ula Hwang, Laurie Ivey, Grant Iverson, Joel Kramer, Melinda Lantz, Lisa Latts, Ana Maria Lopez, Michael Malone, Lori Martin-Plank, Katie Maslow, Don Melady, Melissa Messer, Randi Most, Margaret P Norris, David Shafer, Colin M Thomas, Laura Thornhill, Jean Tsai, Nirav Vakharia, Martin Waters, Tamara Golden,

In December 2017, the National Academy of Neuropsychology convened an interorganizational Summit on Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients in Denver, Colorado. The Summit brought together representatives of a broad range of stakeholders invested in the care of older adults to focus on the topic of ... Read more >>

Clin Neuropsychol (The Clinical neuropsychologist)
[2018, 32(7):1193-1225]

Cited: 1 time

View full text PDF listing >>



Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients.

William Perry, Laura Lacritz, Tresa Roebuck-Spencer, Cheryl Silver, Robert L Denney, John Meyers, Charles E McConnel, Neil Pliskin, Deb Adler, Christopher Alban, Mark Bondi, Michelle Braun, Xavier Cagigas, Morgan Daven, Lisa Drozdick, Norman L Foster, Ula Hwang, Laurie Ivey, Grant Iverson, Joel Kramer, Melinda Lantz, Lisa Latts, Shari M Ling, Ana Maria Lopez, Michael Malone, Lori Martin-Plank, Katie Maslow, Don Melady, Melissa Messer, Randi Most, Margaret P Norris, David Shafer, Nina Silverberg, Colin M Thomas, Laura Thornhill, Jean Tsai, Nirav Vakharia, Martin Waters, Tamara Golden,

In December 2017, the National Academy of Neuropsychology convened an interorganizational Summit on Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients in Denver, Colorado. The Summit brought together representatives of a broad range of stakeholders invested in the care of older adults to focus on the topic of ... Read more >>

Innov Aging (Innovation in aging)
[2018, 2(2):igy025]

Cited: 3 times

View full text PDF listing >>



The impact of β-amyloid positron emission tomography on the diagnostic and treatment decisions of dementia experts.

Michael L Ganz, Alie F Tawah, Shien Guo, Abhishek S Chitnis, Hedwig Silies, Barbara Schäuble, Aleksandar Jovalekic, Norman L Foster,

Amyloid positron emission tomography (aPET) measurement of Alzheimer's disease (AD) pathology could improve the accurate diagnosis of cognitive disorders. Appropriate use criteria recommend that only dementia experts order aPET.We surveyed 145 dementia experts about their current approaches to evaluation and treatment and the likely influence of aPET.Experts expected aPET to ... Read more >>

Neurodegener Dis Manag (Neurodegenerative disease management)
[2017, 7(2):107-117]

Cited: 0 times

View full text PDF listing >>



Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults.

Dustin B Hammers, Taylor J Atkinson, Bonnie C A Dalley, Kayla R Suhrie, Britney E Beardmore, Lance D Burrell, Kevin P Horn, Kelli M Rasmussen, Norman L Foster, Kevin Duff, John M Hoffman,

OBJECTIVE:The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) has been used extensively for clinical care and in research for patients with mild cognitive impairment and Alzheimer's disease (AD); however, relatively few studies have evaluated the relationship between RBANS performance and AD imaging biomarkers. The purpose of the current ... Read more >>

Clin Neuropsychol (The Clinical neuropsychologist)
[2017, 31(3):531-543]

Cited: 1 time

View full text PDF listing >>



Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.

Michael M Witte, Norman L Foster, Adam S Fleisher, Monique M Williams, Kimberly Quaid, Michael Wasserman, Gail Hunt, J Scott Roberts, Gil D Rabinovici, James L Levenson, Ann Marie Hake, Craig A Hunter, Luann E Van Campen, Michael J Pontecorvo, Helen M Hochstetler, Linda B Tabas, Paula T Trzepacz,

Until recently, estimation of β-amyloid plaque density as a key element for identifying Alzheimer's disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with amyloid-positron emission tomography (amyloid-PET) neuroimaging, this AD hallmark can be detected antemortem. Practitioners and patients need to better understand potential ... Read more >>

(Alzheimer's & dementia (Amsterdam, Netherlands))
[2015, 1(3):358-367]

Cited: 11 times

View full text PDF listing >>



The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.

William J Jagust, Susan M Landau, Robert A Koeppe, Eric M Reiman, Kewei Chen, Chester A Mathis, Julie C Price, Norman L Foster, Angela Y Wang,

This article reviews the work done in the Alzheimer's Disease Neuroimaging Initiative positron emission tomography (ADNI PET) core over the past 5 years, largely concerning techniques, methods, and results related to amyloid imaging in ADNI.The PET Core has used [(18)F]florbetapir routinely on ADNI participants, with over 1600 scans available for download. ... Read more >>

Alzheimers Dement (Alzheimer's & dementia : the journal of the Alzheimer's Association)
[2015, 11(7):757-771]

Cited: 47 times

View full text PDF listing >>



Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.

Jon B Toledo, Maria Bjerke, Xiao Da, Susan M Landau, Norman L Foster, William Jagust, Clifford Jack, Michael Weiner, Christos Davatzikos, Leslie M Shaw, John Q Trojanowski, ,

Cerebrospinal fluid (CSF) and positron emission tomographic (PET) amyloid biomarkers have been proposed for the detection of Alzheimer disease (AD) pathology in living patients and for the tracking of longitudinal changes, but the relation between biomarkers needs further study.To determine the association between CSF and PET amyloid biomarkers (cross-sectional and ... Read more >>

JAMA Neurol (JAMA neurology)
[2015, 72(5):571-581]

Cited: 45 times

View full text PDF listing >>



Short-Term Practice Effects and Brain Hypometabolism: Preliminary Data from an FDG PET Study.

Kevin Duff, Kevin P Horn, Norman L Foster, John M Hoffman,

Practice effects are improvements in cognitive test scores due to repeated exposure to the same tests. Typically viewed as error, short-term practice effects have been shown to provide valuable clinical information about diagnosis, prognosis, and treatment outcomes in older patients with mild cognitive impairments. This study examined short-term practice effects ... Read more >>

Arch Clin Neuropsychol (Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists)
[2015, 30(3):264-270]

Cited: 8 times

View full text PDF listing >>



Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system.

Kendra L Puig, Brianna M Lutz, Siri A Urquhart, Andrew A Rebel, Xudong Zhou, Gunjan D Manocha, MaryAnn Sens, Ashok K Tuteja, Norman L Foster, Colin K Combs,

Alzheimer's disease (AD) is a neurodegenerative disorder histologically characterized by amyloid-β (Aβ) protein accumulation and activation of associated microglia. Although these features are well described in the central nervous system, the process and consequences of Aβ accumulation in the enteric nervous system have not been extensively studied. We hypothesized that ... Read more >>

J Alzheimers Dis (Journal of Alzheimer's disease : JAD)
[2015, 44(4):1263-1278]

Cited: 16 times

View full text PDF listing >>



Perceptions of tissue storage in a dementia population among spouses and offspring.

Megan M Martin, Erin W Rothwell, Vickie L Venne, Norman L Foster,

Cognitively impaired patients with dementia often rely on health advocates or guardians, such as spouses or adult offspring, to consent for medical procedures. These family members may also decide whether an autopsy is performed after death or whether their family member donates tissues. However, spouses are not genetically related to ... Read more >>

J Genet Couns (Journal of genetic counseling)
[2015, 24(3):503-511]

Cited: 0 times

View full text PDF listing >>



The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data.

Mark E Schmidt, Ping Chiao, Gregory Klein, Dawn Matthews, Lennart Thurfjell, Patricia E Cole, Richard Margolin, Susan Landau, Norman L Foster, N Scott Mason, Susan De Santi, Joyce Suhy, Robert A Koeppe, William Jagust, ,

In vivo imaging of amyloid burden with positron emission tomography (PET) provides a means for studying the pathophysiology of Alzheimer's and related diseases. Measurement of subtle changes in amyloid burden requires quantitative analysis of image data. Reliable quantitative analysis of amyloid PET scans acquired at multiple sites and over time requires ... Read more >>

Alzheimers Dement (Alzheimer's & dementia : the journal of the Alzheimer's Association)
[2015, 11(9):1050-1068]

Cited: 32 times

View full text PDF listing >>



Factors associated with cognitive evaluations in the United States.

Vikas Kotagal, Kenneth M Langa, Brenda L Plassman, Gwenith G Fisher, Bruno J Giordani, Robert B Wallace, James R Burke, David C Steffens, Mohammed Kabeto, Roger L Albin, Norman L Foster,

We aimed to explore factors associated with clinical evaluations for cognitive impairment among older residents of the United States.Two hundred ninety-seven of 845 subjects in the Aging, Demographics, and Memory Study (ADAMS), a nationally representative community-based cohort study, met criteria for dementia after a detailed in-person study examination. Informants for ... Read more >>

Neurology (Neurology)
[2015, 84(1):64-71]

Cited: 17 times

View full text PDF listing >>



Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence.

Norman L Foster, Judith S M Hackett, Greg White, Sherri Chenevert, Patrick Svarvar, Lisa Bain, Maria C Carrillo,

The increasing cost of health care combined with expensive new drugs and diagnostics is leading to more frequent gaps between regulatory and subsequent reimbursement approval decisions. As a result, persons with Alzheimer's disease may have difficulty accessing the benefit of medical advances. In contrast to the long history and established ... Read more >>

Alzheimers Dement (Alzheimer's & dementia : the journal of the Alzheimer's Association)
[2014, 10(4):503-508]

Cited: 4 times

View full text PDF listing >>



Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.

Kevin Duff, Norman L Foster, John M Hoffman,

Clinical trials in Alzheimer disease are moving toward prevention studies in prodromal individuals with amyloid burden. However, methods are needed to identify individuals expected to be amyloid positive for these studies to be feasible and cost-effective. The current study sought to determine whether short-term practice effects on cognitive tests can ... Read more >>

Alzheimer Dis Assoc Disord (Alzheimer disease and associated disorders)
[2014, 28(3):247-252]

Cited: 15 times

View full text PDF listing >>



Relationship of hearing loss and dementia: a prospective, population-based study.

Richard Klaus Gurgel, Preston Daniel Ward, Sarah Schwartz, Maria C Norton, Norman L Foster, JoAnn T Tschanz,

To determine whether baseline hearing loss increases cognitive decline and risk for all-cause dementia in a population of elderly individuals.Longitudinal cohort study.Community-based, outpatient.Men and women aged 65 years or older without dementia at baseline.All subjects completed the Modified Mini-Mental Status Exam (3MS-R) at baseline and over 3 triennial follow-up visits. ... Read more >>

Otol Neurotol (Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology)
[2014, 35(5):775-781]

Cited: 90 times

View full text PDF listing >>



Coverage with evidence development: what to consider.

Norman L Foster, Karen Mottola, John M Hoffman,

JAMA Neurol (JAMA neurology)
[2014, 71(4):399-400]

Cited: 2 times

View full text PDF listing >>



Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education.

Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Saima Hedrick, Virginia Pappas, Maria C Carrillo, Dean M Hartley,

Amyloid PET imaging is a novel diagnostic test that can detect in living humans one of the two defining pathologic lesions of Alzheimer disease, amyloid-β deposition in the brain. The Amyloid Imaging Task Force of the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging previously published appropriate use ... Read more >>

J. Nucl. Med. (Journal of nuclear medicine : official publication, Society of Nuclear Medicine)
[2013, 54(7):1011-1013]

Cited: 22 times

View full text PDF listing >>



Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.

Keith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, Kevin J Donohoe, Norman L Foster, Peter Herscovitch, Jason H Karlawish, Christopher C Rowe, Saima Hedrick, Virginia Pappas, Maria C Carrillo, Dean M Hartley, ,

Amyloid PET imaging is a novel diagnostic test that can detect in living humans one of the two defining pathologic lesions of Alzheimer disease, amyloid-β deposition in the brain. The Amyloid Imaging Task Force of the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging previously published appropriate use ... Read more >>

Alzheimers Dement (Alzheimer's & dementia : the journal of the Alzheimer's Association)
[2013, 9(4):e106-9]

Cited: 36 times

View full text PDF listing >>



Amyloid deposition and cognition in older adults: the effects of premorbid intellect.

Kevin Duff, Norman L Foster, Kathryn Dennett, Dustin B Hammers, Lauren V Zollinger, Paul E Christian, Regan I Butterfield, Britney E Beardmore, Angela Y Wang, Kathryn A Morton, John M Hoffman,

Although amyloid deposition remains a marker of the development of Alzheimer's disease, results linking amyloid and cognition have been equivocal. Twenty-five community-dwelling non-demented older adults were examined with (18)F-flutemetamol, an amyloid imaging agent, and a cognitive battery, including an estimate of premorbid intellect and the Repeatable Battery for the Assessment ... Read more >>

Arch Clin Neuropsychol (Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists)
[2013, 28(7):665-671]

Cited: 13 times

View full text PDF listing >>



Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study.

John S K Kauwe, Perry G Ridge, Norman L Foster, Lisa A Cannon-Albright,

BACKGROUND:Alzheimer's disease (AD) is an international health concern that has a devastating effect on patients and families. While several genetic risk factors for AD have been identified much of the genetic variance in AD remains unexplained. There are limited published assessments of the familiality of Alzheimer's disease. Here we present ... Read more >>

PLoS One (PloS one)
[2013, 8(10):e77087]

Cited: 9 times

View full text PDF listing >>



Advertisement

Disclaimer
1.087 s